GovChime
Notice ID: ee2bae7196ed410ba4cd360b53e7440cAward NoticeAwarded

Manipulating Ghrelin signaling via GOAT inhibition in alcohol use disorder.

Awarded on August 5, 2022. Full description on SAM.gov.

Awarded tounder 75N95022P00407 (source: SAM.gov award notice)• $71.1K

Overview

Posted
August 5, 2022
Notice type
Award Notice
NAICS
541380: Testing Laboratories and Services
Agency
Department of Health and Human Services

Notice details

Place of performance
Baltimore, MD
Last updated
Dec 4, 2025
Award date
Aug 5, 2022
Award amount (SAM.gov award notice)
$71.1K

Identifiers

Solicitation number
75N95022Q00400
Notice ID
ee2bae7196ed410ba4cd360b53e7440c
Award number (PIID)
75N95022P00407

Description

For purchases not exceeding the simplified acquisition threshold, contracting officers may solicit from one source if the contracting officer determines that the circumstances of the contract action deem only one source reasonably available (e.g., urgency, exclusive licensing agreements, brand-name or industrial mobilization). This contract WAS awarded to Alcami Carolinas Corporation, 2320 Scientific Park DR, Wilmington, North Carolina 28405, to perform the stability testing on the ongoing study drug GLWL-01 in relation to alcohol related behavior.

Full description on SAM.gov

Award Overview

Award Number

75N95022P00407

Award Amount (SAM.gov award notice)

$71.1K

Award Date

Aug 5, 2022

Awardee

Awardee UEI

D2DHUF4NTK23

Original Solicitation

Notice ID: ee2bae7196ed410ba4cd360b53e7440c

Posted Date: Aug 5, 2022

Original Response Deadline: Not specified

More From This Vendor

Top 5 most recent

2
  • 75N98027P00060
    ALCAMI CAROLINAS CORPORATION
    Department of Health and Human ServicesNAICS 541380
    $31.1KSigned Nov 10, 2026
  • 75N92026P00018
    ALCAMI CAROLINAS CORPORATION
    Department of Health and Human ServicesNAICS 541380
    $60.0KSigned Dec 8, 2025

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75N95022Q00400
  1. Awarded

This opportunity has been awarded.

  1. Special NoticeJul 12, 2022

    Manipulating Ghrelin signaling via GOAT inhibition in alcohol use disorder.

    Notice 3a0a20db0fc04f47b7c5cfb9276c00e9 on SAM.gov

  2. AwardedCurrentAug 5, 2022

    Manipulating Ghrelin signaling via GOAT inhibition in alcohol use disorder.

    Notice ee2bae7196ed410ba4cd360b53e7440c on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N95022Q00400

Archive Date

Aug 20, 2022

Office Address

Bethesda, MD, 20892